nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—CYP1A2—type 2 diabetes mellitus	0.219	0.607	CbGaD
Nabumetone—PTGS2—type 2 diabetes mellitus	0.142	0.393	CbGaD
Nabumetone—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0674	0.177	CbGbCtD
Nabumetone—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0674	0.177	CbGbCtD
Nabumetone—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0622	0.163	CbGbCtD
Nabumetone—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0511	0.134	CbGbCtD
Nabumetone—PTGS1—Irbesartan—type 2 diabetes mellitus	0.049	0.128	CbGbCtD
Nabumetone—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0278	0.0728	CbGbCtD
Nabumetone—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0219	0.0574	CbGbCtD
Nabumetone—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0207	0.0542	CbGbCtD
Nabumetone—CYP1A2—Losartan—type 2 diabetes mellitus	0.0141	0.037	CbGbCtD
Nabumetone—MPO—artery—type 2 diabetes mellitus	0.00231	0.127	CbGeAlD
Nabumetone—MPO—endothelium—type 2 diabetes mellitus	0.00195	0.107	CbGeAlD
Nabumetone—Agomelatine—MTNR1A—type 2 diabetes mellitus	0.00192	0.327	CrCbGaD
Nabumetone—PTGS2—leg—type 2 diabetes mellitus	0.00191	0.105	CbGeAlD
Nabumetone—PTGS2—hindlimb—type 2 diabetes mellitus	0.00171	0.0939	CbGeAlD
Nabumetone—Melatonin—MTNR1A—type 2 diabetes mellitus	0.00112	0.192	CrCbGaD
Nabumetone—PTGS1—artery—type 2 diabetes mellitus	0.0011	0.0602	CbGeAlD
Nabumetone—PTGS2—artery—type 2 diabetes mellitus	0.00105	0.0576	CbGeAlD
Nabumetone—Agomelatine—MTNR1B—type 2 diabetes mellitus	0.00101	0.172	CrCbGaD
Nabumetone—PTGS1—endothelium—type 2 diabetes mellitus	0.000926	0.0509	CbGeAlD
Nabumetone—PTGS2—endothelium—type 2 diabetes mellitus	0.000885	0.0486	CbGeAlD
Nabumetone—MPO—cardiovascular system—type 2 diabetes mellitus	0.000803	0.0441	CbGeAlD
Nabumetone—MPO—kidney—type 2 diabetes mellitus	0.000786	0.0432	CbGeAlD
Nabumetone—MPO—pancreas—type 2 diabetes mellitus	0.000781	0.0429	CbGeAlD
Nabumetone—Melatonin—MTNR1B—type 2 diabetes mellitus	0.00059	0.101	CrCbGaD
Nabumetone—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000504	0.0277	CbGeAlD
Nabumetone—MPO—liver—type 2 diabetes mellitus	0.000497	0.0273	CbGeAlD
Nabumetone—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000381	0.0209	CbGeAlD
Nabumetone—PTGS1—kidney—type 2 diabetes mellitus	0.000373	0.0205	CbGeAlD
Nabumetone—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000364	0.02	CbGeAlD
Nabumetone—Melatonin—CALM1—type 2 diabetes mellitus	0.000362	0.0617	CrCbGaD
Nabumetone—PTGS2—kidney—type 2 diabetes mellitus	0.000356	0.0196	CbGeAlD
Nabumetone—PTGS2—pancreas—type 2 diabetes mellitus	0.000354	0.0195	CbGeAlD
Nabumetone—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000336	0.0185	CbGeAlD
Nabumetone—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000321	0.0176	CbGeAlD
Nabumetone—CYP1A2—liver—type 2 diabetes mellitus	0.000272	0.0149	CbGeAlD
Nabumetone—Agomelatine—HTR2C—type 2 diabetes mellitus	0.000257	0.0439	CrCbGaD
Nabumetone—PTGS2—liver—type 2 diabetes mellitus	0.000225	0.0124	CbGeAlD
Nabumetone—Agomelatine—CYP1A2—type 2 diabetes mellitus	0.000194	0.0331	CrCbGaD
Nabumetone—Naproxen—CYP1A2—type 2 diabetes mellitus	0.000132	0.0225	CrCbGaD
Nabumetone—Melatonin—CYP1A2—type 2 diabetes mellitus	0.000114	0.0194	CrCbGaD
Nabumetone—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000113	0.000691	CcSEcCtD
Nabumetone—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000113	0.000689	CcSEcCtD
Nabumetone—Anorexia—Valsartan—type 2 diabetes mellitus	0.000113	0.000688	CcSEcCtD
Nabumetone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000112	0.000687	CcSEcCtD
Nabumetone—Malaise—Irbesartan—type 2 diabetes mellitus	0.000112	0.000685	CcSEcCtD
Nabumetone—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000112	0.000683	CcSEcCtD
Nabumetone—Headache—Pioglitazone—type 2 diabetes mellitus	0.000112	0.000682	CcSEcCtD
Nabumetone—Syncope—Irbesartan—type 2 diabetes mellitus	0.000111	0.000681	CcSEcCtD
Nabumetone—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000111	0.00068	CcSEcCtD
Nabumetone—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000111	0.000679	CcSEcCtD
Nabumetone—Discomfort—Metformin—type 2 diabetes mellitus	0.000111	0.000677	CcSEcCtD
Nabumetone—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000111	0.000677	CcSEcCtD
Nabumetone—Nausea—Glipizide—type 2 diabetes mellitus	0.00011	0.000675	CcSEcCtD
Nabumetone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00011	0.000674	CcSEcCtD
Nabumetone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00011	0.000672	CcSEcCtD
Nabumetone—Constipation—Gliclazide—type 2 diabetes mellitus	0.00011	0.000672	CcSEcCtD
Nabumetone—Tremor—Losartan—type 2 diabetes mellitus	0.00011	0.00067	CcSEcCtD
Nabumetone—Rash—Glimepiride—type 2 diabetes mellitus	0.000109	0.000669	CcSEcCtD
Nabumetone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000109	0.000668	CcSEcCtD
Nabumetone—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000109	0.000668	CcSEcCtD
Nabumetone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000109	0.000667	CcSEcCtD
Nabumetone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000109	0.000666	CcSEcCtD
Nabumetone—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000109	0.000666	CcSEcCtD
Nabumetone—Headache—Glimepiride—type 2 diabetes mellitus	0.000109	0.000664	CcSEcCtD
Nabumetone—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000109	0.000663	CcSEcCtD
Nabumetone—Cough—Irbesartan—type 2 diabetes mellitus	0.000108	0.000663	CcSEcCtD
Nabumetone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000108	0.000662	CcSEcCtD
Nabumetone—Anaemia—Losartan—type 2 diabetes mellitus	0.000108	0.000661	CcSEcCtD
Nabumetone—Agitation—Losartan—type 2 diabetes mellitus	0.000108	0.000657	CcSEcCtD
Nabumetone—Oedema—Metformin—type 2 diabetes mellitus	0.000108	0.000657	CcSEcCtD
Nabumetone—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000107	0.000657	CcSEcCtD
Nabumetone—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000107	0.000656	CcSEcCtD
Nabumetone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000107	0.000655	CcSEcCtD
Nabumetone—Angioedema—Losartan—type 2 diabetes mellitus	0.000107	0.000653	CcSEcCtD
Nabumetone—Insomnia—Valsartan—type 2 diabetes mellitus	0.000107	0.000653	CcSEcCtD
Nabumetone—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000106	0.000648	CcSEcCtD
Nabumetone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000106	0.000647	CcSEcCtD
Nabumetone—Shock—Metformin—type 2 diabetes mellitus	0.000106	0.000647	CcSEcCtD
Nabumetone—Insomnia—Orlistat—type 2 diabetes mellitus	0.000106	0.000645	CcSEcCtD
Nabumetone—Malaise—Losartan—type 2 diabetes mellitus	0.000106	0.000645	CcSEcCtD
Nabumetone—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000105	0.000645	CcSEcCtD
Nabumetone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000105	0.000644	CcSEcCtD
Nabumetone—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000105	0.000643	CcSEcCtD
Nabumetone—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000105	0.000643	CcSEcCtD
Nabumetone—Vertigo—Losartan—type 2 diabetes mellitus	0.000105	0.000642	CcSEcCtD
Nabumetone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000105	0.000642	CcSEcCtD
Nabumetone—Somnolence—Valsartan—type 2 diabetes mellitus	0.000105	0.000642	CcSEcCtD
Nabumetone—Syncope—Losartan—type 2 diabetes mellitus	0.000105	0.000641	CcSEcCtD
Nabumetone—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000105	0.00064	CcSEcCtD
Nabumetone—Leukopenia—Losartan—type 2 diabetes mellitus	0.000105	0.00064	CcSEcCtD
Nabumetone—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000105	0.000639	CcSEcCtD
Nabumetone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000104	0.000635	CcSEcCtD
Nabumetone—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000104	0.000635	CcSEcCtD
Nabumetone—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000633	CcSEcCtD
Nabumetone—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000104	0.000633	CcSEcCtD
Nabumetone—Palpitations—Losartan—type 2 diabetes mellitus	0.000103	0.000632	CcSEcCtD
Nabumetone—Nausea—Glimepiride—type 2 diabetes mellitus	0.000103	0.00063	CcSEcCtD
Nabumetone—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000103	0.000629	CcSEcCtD
Nabumetone—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000103	0.000629	CcSEcCtD
Nabumetone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000103	0.000628	CcSEcCtD
Nabumetone—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000103	0.000628	CcSEcCtD
Nabumetone—Asthenia—Glyburide—type 2 diabetes mellitus	0.000103	0.000628	CcSEcCtD
Nabumetone—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000103	0.000627	CcSEcCtD
Nabumetone—Anorexia—Metformin—type 2 diabetes mellitus	0.000102	0.000626	CcSEcCtD
Nabumetone—Cough—Losartan—type 2 diabetes mellitus	0.000102	0.000624	CcSEcCtD
Nabumetone—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000102	0.000624	CcSEcCtD
Nabumetone—Alopecia—Ramipril—type 2 diabetes mellitus	0.000102	0.000622	CcSEcCtD
Nabumetone—Fatigue—Valsartan—type 2 diabetes mellitus	0.000102	0.000622	CcSEcCtD
Nabumetone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000102	0.000621	CcSEcCtD
Nabumetone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000102	0.000621	CcSEcCtD
Nabumetone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000101	0.00062	CcSEcCtD
Nabumetone—Oedema—Irbesartan—type 2 diabetes mellitus	0.000101	0.00062	CcSEcCtD
Nabumetone—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000101	0.00062	CcSEcCtD
Nabumetone—Pruritus—Glyburide—type 2 diabetes mellitus	0.000101	0.000619	CcSEcCtD
Nabumetone—Constipation—Valsartan—type 2 diabetes mellitus	0.000101	0.000617	CcSEcCtD
Nabumetone—Fatigue—Orlistat—type 2 diabetes mellitus	0.000101	0.000615	CcSEcCtD
Nabumetone—Shock—Irbesartan—type 2 diabetes mellitus	9.98e-05	0.00061	CcSEcCtD
Nabumetone—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.95e-05	0.000608	CcSEcCtD
Nabumetone—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.94e-05	0.000607	CcSEcCtD
Nabumetone—Anxiety—Losartan—type 2 diabetes mellitus	9.93e-05	0.000607	CcSEcCtD
Nabumetone—Rash—Bromocriptine—type 2 diabetes mellitus	9.87e-05	0.000603	CcSEcCtD
Nabumetone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.86e-05	0.000603	CcSEcCtD
Nabumetone—Tension—Ramipril—type 2 diabetes mellitus	9.85e-05	0.000602	CcSEcCtD
Nabumetone—Discomfort—Losartan—type 2 diabetes mellitus	9.84e-05	0.000602	CcSEcCtD
Nabumetone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.81e-05	0.0006	CcSEcCtD
Nabumetone—Headache—Bromocriptine—type 2 diabetes mellitus	9.81e-05	0.000599	CcSEcCtD
Nabumetone—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.79e-05	0.000598	CcSEcCtD
Nabumetone—Nervousness—Ramipril—type 2 diabetes mellitus	9.74e-05	0.000596	CcSEcCtD
Nabumetone—Dry mouth—Losartan—type 2 diabetes mellitus	9.74e-05	0.000595	CcSEcCtD
Nabumetone—Anorexia—Irbesartan—type 2 diabetes mellitus	9.67e-05	0.000591	CcSEcCtD
Nabumetone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	9.66e-05	0.00059	CcSEcCtD
Nabumetone—Paraesthesia—Metformin—type 2 diabetes mellitus	9.66e-05	0.00059	CcSEcCtD
Nabumetone—Confusional state—Losartan—type 2 diabetes mellitus	9.63e-05	0.000588	CcSEcCtD
Nabumetone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	9.61e-05	0.000588	CcSEcCtD
Nabumetone—Dyspnoea—Metformin—type 2 diabetes mellitus	9.59e-05	0.000586	CcSEcCtD
Nabumetone—Somnolence—Metformin—type 2 diabetes mellitus	9.56e-05	0.000584	CcSEcCtD
Nabumetone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	9.55e-05	0.000584	CcSEcCtD
Nabumetone—Oedema—Losartan—type 2 diabetes mellitus	9.55e-05	0.000584	CcSEcCtD
Nabumetone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.54e-05	0.000583	CcSEcCtD
Nabumetone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.47e-05	0.000579	CcSEcCtD
Nabumetone—Dyspepsia—Metformin—type 2 diabetes mellitus	9.47e-05	0.000578	CcSEcCtD
Nabumetone—Tremor—Ramipril—type 2 diabetes mellitus	9.4e-05	0.000574	CcSEcCtD
Nabumetone—Shock—Losartan—type 2 diabetes mellitus	9.4e-05	0.000574	CcSEcCtD
Nabumetone—Urticaria—Valsartan—type 2 diabetes mellitus	9.38e-05	0.000573	CcSEcCtD
Nabumetone—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.35e-05	0.000571	CcSEcCtD
Nabumetone—Decreased appetite—Metformin—type 2 diabetes mellitus	9.35e-05	0.000571	CcSEcCtD
Nabumetone—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.33e-05	0.00057	CcSEcCtD
Nabumetone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9.31e-05	0.000569	CcSEcCtD
Nabumetone—Nausea—Bromocriptine—type 2 diabetes mellitus	9.3e-05	0.000568	CcSEcCtD
Nabumetone—Fatigue—Metformin—type 2 diabetes mellitus	9.27e-05	0.000567	CcSEcCtD
Nabumetone—Urticaria—Orlistat—type 2 diabetes mellitus	9.27e-05	0.000566	CcSEcCtD
Nabumetone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.23e-05	0.000564	CcSEcCtD
Nabumetone—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.22e-05	0.000564	CcSEcCtD
Nabumetone—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.22e-05	0.000564	CcSEcCtD
Nabumetone—Asthenia—Gliclazide—type 2 diabetes mellitus	9.22e-05	0.000564	CcSEcCtD
Nabumetone—Agitation—Ramipril—type 2 diabetes mellitus	9.22e-05	0.000563	CcSEcCtD
Nabumetone—Constipation—Metformin—type 2 diabetes mellitus	9.2e-05	0.000562	CcSEcCtD
Nabumetone—Angioedema—Ramipril—type 2 diabetes mellitus	9.17e-05	0.00056	CcSEcCtD
Nabumetone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.11e-05	0.000557	CcSEcCtD
Nabumetone—Anorexia—Losartan—type 2 diabetes mellitus	9.1e-05	0.000556	CcSEcCtD
Nabumetone—Vomiting—Glyburide—type 2 diabetes mellitus	9.1e-05	0.000556	CcSEcCtD
Nabumetone—Pruritus—Gliclazide—type 2 diabetes mellitus	9.09e-05	0.000556	CcSEcCtD
Nabumetone—Malaise—Ramipril—type 2 diabetes mellitus	9.05e-05	0.000553	CcSEcCtD
Nabumetone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.000553	CcSEcCtD
Nabumetone—Rash—Glyburide—type 2 diabetes mellitus	9.02e-05	0.000552	CcSEcCtD
Nabumetone—Somnolence—Irbesartan—type 2 diabetes mellitus	9.02e-05	0.000551	CcSEcCtD
Nabumetone—Dermatitis—Glyburide—type 2 diabetes mellitus	9.02e-05	0.000551	CcSEcCtD
Nabumetone—Vertigo—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000551	CcSEcCtD
Nabumetone—Syncope—Ramipril—type 2 diabetes mellitus	9e-05	0.00055	CcSEcCtD
Nabumetone—Leukopenia—Ramipril—type 2 diabetes mellitus	8.98e-05	0.000549	CcSEcCtD
Nabumetone—Headache—Glyburide—type 2 diabetes mellitus	8.97e-05	0.000548	CcSEcCtD
Nabumetone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.93e-05	0.000546	CcSEcCtD
Nabumetone—Palpitations—Ramipril—type 2 diabetes mellitus	8.87e-05	0.000542	CcSEcCtD
Nabumetone—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.86e-05	0.000542	CcSEcCtD
Nabumetone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.82e-05	0.000539	CcSEcCtD
Nabumetone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	8.82e-05	0.000539	CcSEcCtD
Nabumetone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.79e-05	0.000537	CcSEcCtD
Nabumetone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.79e-05	0.000537	CcSEcCtD
Nabumetone—Cough—Ramipril—type 2 diabetes mellitus	8.76e-05	0.000535	CcSEcCtD
Nabumetone—Fatigue—Irbesartan—type 2 diabetes mellitus	8.75e-05	0.000535	CcSEcCtD
Nabumetone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.7e-05	0.000532	CcSEcCtD
Nabumetone—Constipation—Irbesartan—type 2 diabetes mellitus	8.68e-05	0.00053	CcSEcCtD
Nabumetone—Insomnia—Losartan—type 2 diabetes mellitus	8.64e-05	0.000528	CcSEcCtD
Nabumetone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.6e-05	0.000525	CcSEcCtD
Nabumetone—Paraesthesia—Losartan—type 2 diabetes mellitus	8.57e-05	0.000524	CcSEcCtD
Nabumetone—Naproxen—PTGS2—type 2 diabetes mellitus	8.56e-05	0.0146	CrCbGaD
Nabumetone—Urticaria—Metformin—type 2 diabetes mellitus	8.54e-05	0.000522	CcSEcCtD
Nabumetone—Dyspnoea—Losartan—type 2 diabetes mellitus	8.51e-05	0.00052	CcSEcCtD
Nabumetone—Anxiety—Ramipril—type 2 diabetes mellitus	8.51e-05	0.00052	CcSEcCtD
Nabumetone—Nausea—Glyburide—type 2 diabetes mellitus	8.5e-05	0.00052	CcSEcCtD
Nabumetone—Abdominal pain—Metformin—type 2 diabetes mellitus	8.5e-05	0.000519	CcSEcCtD
Nabumetone—Dizziness—Gliclazide—type 2 diabetes mellitus	8.5e-05	0.000519	CcSEcCtD
Nabumetone—Somnolence—Losartan—type 2 diabetes mellitus	8.49e-05	0.000519	CcSEcCtD
Nabumetone—Asthenia—Valsartan—type 2 diabetes mellitus	8.47e-05	0.000518	CcSEcCtD
Nabumetone—Discomfort—Ramipril—type 2 diabetes mellitus	8.44e-05	0.000516	CcSEcCtD
Nabumetone—Dyspepsia—Losartan—type 2 diabetes mellitus	8.41e-05	0.000514	CcSEcCtD
Nabumetone—Asthenia—Orlistat—type 2 diabetes mellitus	8.37e-05	0.000512	CcSEcCtD
Nabumetone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.36e-05	0.000511	CcSEcCtD
Nabumetone—Pruritus—Valsartan—type 2 diabetes mellitus	8.35e-05	0.000511	CcSEcCtD
Nabumetone—Dry mouth—Ramipril—type 2 diabetes mellitus	8.35e-05	0.000511	CcSEcCtD
Nabumetone—Decreased appetite—Losartan—type 2 diabetes mellitus	8.3e-05	0.000507	CcSEcCtD
Nabumetone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.3e-05	0.000507	CcSEcCtD
Nabumetone—Confusional state—Ramipril—type 2 diabetes mellitus	8.26e-05	0.000505	CcSEcCtD
Nabumetone—Pruritus—Orlistat—type 2 diabetes mellitus	8.25e-05	0.000504	CcSEcCtD
Nabumetone—Fatigue—Losartan—type 2 diabetes mellitus	8.23e-05	0.000503	CcSEcCtD
Nabumetone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.19e-05	0.0005	CcSEcCtD
Nabumetone—Oedema—Ramipril—type 2 diabetes mellitus	8.19e-05	0.0005	CcSEcCtD
Nabumetone—Vomiting—Gliclazide—type 2 diabetes mellitus	8.17e-05	0.000499	CcSEcCtD
Nabumetone—Constipation—Losartan—type 2 diabetes mellitus	8.17e-05	0.000499	CcSEcCtD
Nabumetone—Rash—Gliclazide—type 2 diabetes mellitus	8.1e-05	0.000495	CcSEcCtD
Nabumetone—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.1e-05	0.000495	CcSEcCtD
Nabumetone—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.08e-05	0.000494	CcSEcCtD
Nabumetone—Urticaria—Irbesartan—type 2 diabetes mellitus	8.06e-05	0.000493	CcSEcCtD
Nabumetone—Shock—Ramipril—type 2 diabetes mellitus	8.06e-05	0.000492	CcSEcCtD
Nabumetone—Headache—Gliclazide—type 2 diabetes mellitus	8.05e-05	0.000492	CcSEcCtD
Nabumetone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.02e-05	0.00049	CcSEcCtD
Nabumetone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.02e-05	0.00049	CcSEcCtD
Nabumetone—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.02e-05	0.00049	CcSEcCtD
Nabumetone—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.98e-05	0.000488	CcSEcCtD
Nabumetone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.92e-05	0.000484	CcSEcCtD
Nabumetone—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.87e-05	0.000481	CcSEcCtD
Nabumetone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.81e-05	0.000477	CcSEcCtD
Nabumetone—Dizziness—Valsartan—type 2 diabetes mellitus	7.81e-05	0.000477	CcSEcCtD
Nabumetone—Anorexia—Ramipril—type 2 diabetes mellitus	7.81e-05	0.000477	CcSEcCtD
Nabumetone—Dizziness—Orlistat—type 2 diabetes mellitus	7.72e-05	0.000472	CcSEcCtD
Nabumetone—Asthenia—Metformin—type 2 diabetes mellitus	7.71e-05	0.000471	CcSEcCtD
Nabumetone—Nausea—Gliclazide—type 2 diabetes mellitus	7.63e-05	0.000467	CcSEcCtD
Nabumetone—Naproxen—ALB—type 2 diabetes mellitus	7.63e-05	0.013	CrCbGaD
Nabumetone—Pruritus—Metformin—type 2 diabetes mellitus	7.61e-05	0.000465	CcSEcCtD
Nabumetone—Urticaria—Losartan—type 2 diabetes mellitus	7.59e-05	0.000464	CcSEcCtD
Nabumetone—Abdominal pain—Losartan—type 2 diabetes mellitus	7.55e-05	0.000461	CcSEcCtD
Nabumetone—Body temperature increased—Losartan—type 2 diabetes mellitus	7.55e-05	0.000461	CcSEcCtD
Nabumetone—Vomiting—Valsartan—type 2 diabetes mellitus	7.51e-05	0.000459	CcSEcCtD
Nabumetone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.48e-05	0.000457	CcSEcCtD
Nabumetone—Rash—Valsartan—type 2 diabetes mellitus	7.44e-05	0.000455	CcSEcCtD
Nabumetone—Dermatitis—Valsartan—type 2 diabetes mellitus	7.44e-05	0.000455	CcSEcCtD
Nabumetone—Vomiting—Orlistat—type 2 diabetes mellitus	7.42e-05	0.000453	CcSEcCtD
Nabumetone—Insomnia—Ramipril—type 2 diabetes mellitus	7.41e-05	0.000453	CcSEcCtD
Nabumetone—Headache—Valsartan—type 2 diabetes mellitus	7.4e-05	0.000452	CcSEcCtD
Nabumetone—Diarrhoea—Metformin—type 2 diabetes mellitus	7.36e-05	0.00045	CcSEcCtD
Nabumetone—Rash—Orlistat—type 2 diabetes mellitus	7.36e-05	0.00045	CcSEcCtD
Nabumetone—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.35e-05	0.000449	CcSEcCtD
Nabumetone—Dermatitis—Orlistat—type 2 diabetes mellitus	7.35e-05	0.000449	CcSEcCtD
Nabumetone—Headache—Orlistat—type 2 diabetes mellitus	7.31e-05	0.000447	CcSEcCtD
Nabumetone—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.3e-05	0.000446	CcSEcCtD
Nabumetone—Asthenia—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.000445	CcSEcCtD
Nabumetone—Somnolence—Ramipril—type 2 diabetes mellitus	7.28e-05	0.000445	CcSEcCtD
Nabumetone—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.21e-05	0.000441	CcSEcCtD
Nabumetone—Pruritus—Irbesartan—type 2 diabetes mellitus	7.18e-05	0.000439	CcSEcCtD
Nabumetone—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.12e-05	0.000435	CcSEcCtD
Nabumetone—Dizziness—Metformin—type 2 diabetes mellitus	7.11e-05	0.000435	CcSEcCtD
Nabumetone—Fatigue—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000431	CcSEcCtD
Nabumetone—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.04e-05	0.00043	CcSEcCtD
Nabumetone—Nausea—Valsartan—type 2 diabetes mellitus	7.01e-05	0.000429	CcSEcCtD
Nabumetone—Constipation—Ramipril—type 2 diabetes mellitus	7e-05	0.000428	CcSEcCtD
Nabumetone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.94e-05	0.000424	CcSEcCtD
Nabumetone—Nausea—Orlistat—type 2 diabetes mellitus	6.93e-05	0.000424	CcSEcCtD
Nabumetone—Asthenia—Losartan—type 2 diabetes mellitus	6.85e-05	0.000419	CcSEcCtD
Nabumetone—Vomiting—Metformin—type 2 diabetes mellitus	6.84e-05	0.000418	CcSEcCtD
Nabumetone—Rash—Metformin—type 2 diabetes mellitus	6.78e-05	0.000414	CcSEcCtD
Nabumetone—Dermatitis—Metformin—type 2 diabetes mellitus	6.77e-05	0.000414	CcSEcCtD
Nabumetone—Pruritus—Losartan—type 2 diabetes mellitus	6.76e-05	0.000413	CcSEcCtD
Nabumetone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.75e-05	0.000412	CcSEcCtD
Nabumetone—Headache—Metformin—type 2 diabetes mellitus	6.74e-05	0.000412	CcSEcCtD
Nabumetone—Dizziness—Irbesartan—type 2 diabetes mellitus	6.71e-05	0.00041	CcSEcCtD
Nabumetone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.7e-05	0.000409	CcSEcCtD
Nabumetone—Diarrhoea—Losartan—type 2 diabetes mellitus	6.53e-05	0.000399	CcSEcCtD
Nabumetone—Urticaria—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000398	CcSEcCtD
Nabumetone—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.47e-05	0.000396	CcSEcCtD
Nabumetone—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.47e-05	0.000396	CcSEcCtD
Nabumetone—Vomiting—Irbesartan—type 2 diabetes mellitus	6.45e-05	0.000394	CcSEcCtD
Nabumetone—Rash—Irbesartan—type 2 diabetes mellitus	6.4e-05	0.000391	CcSEcCtD
Nabumetone—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.39e-05	0.000391	CcSEcCtD
Nabumetone—Nausea—Metformin—type 2 diabetes mellitus	6.39e-05	0.00039	CcSEcCtD
Nabumetone—Headache—Irbesartan—type 2 diabetes mellitus	6.36e-05	0.000388	CcSEcCtD
Nabumetone—Dizziness—Losartan—type 2 diabetes mellitus	6.31e-05	0.000386	CcSEcCtD
Nabumetone—Vomiting—Losartan—type 2 diabetes mellitus	6.07e-05	0.000371	CcSEcCtD
Nabumetone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.03e-05	0.000369	CcSEcCtD
Nabumetone—Nausea—Irbesartan—type 2 diabetes mellitus	6.03e-05	0.000368	CcSEcCtD
Nabumetone—Rash—Losartan—type 2 diabetes mellitus	6.02e-05	0.000368	CcSEcCtD
Nabumetone—Dermatitis—Losartan—type 2 diabetes mellitus	6.02e-05	0.000368	CcSEcCtD
Nabumetone—Headache—Losartan—type 2 diabetes mellitus	5.98e-05	0.000366	CcSEcCtD
Nabumetone—Asthenia—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000359	CcSEcCtD
Nabumetone—Pruritus—Ramipril—type 2 diabetes mellitus	5.79e-05	0.000354	CcSEcCtD
Nabumetone—Nausea—Losartan—type 2 diabetes mellitus	5.67e-05	0.000347	CcSEcCtD
Nabumetone—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.6e-05	0.000342	CcSEcCtD
Nabumetone—Dizziness—Ramipril—type 2 diabetes mellitus	5.41e-05	0.000331	CcSEcCtD
Nabumetone—Vomiting—Ramipril—type 2 diabetes mellitus	5.21e-05	0.000318	CcSEcCtD
Nabumetone—Rash—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000316	CcSEcCtD
Nabumetone—Dermatitis—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000315	CcSEcCtD
Nabumetone—Headache—Ramipril—type 2 diabetes mellitus	5.13e-05	0.000313	CcSEcCtD
Nabumetone—Nausea—Ramipril—type 2 diabetes mellitus	4.86e-05	0.000297	CcSEcCtD
Nabumetone—PTGS1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.62e-05	0.000229	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.6e-05	0.000227	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HK1—type 2 diabetes mellitus	1.6e-05	0.000227	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.6e-05	0.000226	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CDO1—type 2 diabetes mellitus	1.6e-05	0.000226	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GPD2—type 2 diabetes mellitus	1.6e-05	0.000226	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CPT1A—type 2 diabetes mellitus	1.59e-05	0.000225	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MTR—type 2 diabetes mellitus	1.59e-05	0.000225	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.56e-05	0.000221	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.56e-05	0.000221	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NAMPT—type 2 diabetes mellitus	1.56e-05	0.00022	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.55e-05	0.00022	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.55e-05	0.000219	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—LIPC—type 2 diabetes mellitus	1.55e-05	0.000219	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HBA1—type 2 diabetes mellitus	1.55e-05	0.000219	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GCK—type 2 diabetes mellitus	1.55e-05	0.000219	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HSD3B2—type 2 diabetes mellitus	1.54e-05	0.000219	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LPA—type 2 diabetes mellitus	1.54e-05	0.000219	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—KCNJ11—type 2 diabetes mellitus	1.54e-05	0.000219	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GCKR—type 2 diabetes mellitus	1.54e-05	0.000219	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.54e-05	0.000218	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SLC2A2—type 2 diabetes mellitus	1.53e-05	0.000218	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AK1—type 2 diabetes mellitus	1.52e-05	0.000216	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.51e-05	0.000214	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.5e-05	0.000213	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTR—type 2 diabetes mellitus	1.5e-05	0.000213	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CETP—type 2 diabetes mellitus	1.49e-05	0.000211	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.49e-05	0.00021	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	1.48e-05	0.00021	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	1.47e-05	0.000209	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GCK—type 2 diabetes mellitus	1.47e-05	0.000208	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IAPP—type 2 diabetes mellitus	1.46e-05	0.000206	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.44e-05	0.000204	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	1.43e-05	0.000203	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.41e-05	0.0002	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MAT1A—type 2 diabetes mellitus	1.4e-05	0.000199	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC5A4—type 2 diabetes mellitus	1.4e-05	0.000199	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.4e-05	0.000198	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.39e-05	0.000197	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.39e-05	0.000197	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PSMD6—type 2 diabetes mellitus	1.39e-05	0.000196	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SNAP25—type 2 diabetes mellitus	1.39e-05	0.000196	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SREBF1—type 2 diabetes mellitus	1.39e-05	0.000196	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	1.38e-05	0.000195	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.37e-05	0.000195	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CTGF—type 2 diabetes mellitus	1.36e-05	0.000193	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.36e-05	0.000193	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.36e-05	0.000192	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HBA2—type 2 diabetes mellitus	1.36e-05	0.000192	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—G6PC—type 2 diabetes mellitus	1.36e-05	0.000192	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ND1—type 2 diabetes mellitus	1.36e-05	0.000192	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ENPP1—type 2 diabetes mellitus	1.36e-05	0.000192	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HMGCR—type 2 diabetes mellitus	1.35e-05	0.000191	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	1.34e-05	0.00019	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.33e-05	0.000189	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.32e-05	0.000187	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	1.31e-05	0.000186	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	1.31e-05	0.000186	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	1.31e-05	0.000186	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	1.29e-05	0.000182	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CYBA—type 2 diabetes mellitus	1.27e-05	0.00018	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.27e-05	0.00018	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	1.26e-05	0.000178	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	1.26e-05	0.000178	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.25e-05	0.000178	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.25e-05	0.000178	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	1.24e-05	0.000176	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	1.24e-05	0.000176	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	1.23e-05	0.000175	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CALCA—type 2 diabetes mellitus	1.23e-05	0.000174	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.23e-05	0.000174	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	1.23e-05	0.000174	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	1.23e-05	0.000174	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	1.23e-05	0.000174	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.22e-05	0.000173	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.22e-05	0.000173	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.22e-05	0.000172	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	1.21e-05	0.000171	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GCG—type 2 diabetes mellitus	1.2e-05	0.00017	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.2e-05	0.00017	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.2e-05	0.00017	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	1.19e-05	0.000168	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	1.18e-05	0.000168	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS1—type 2 diabetes mellitus	1.17e-05	0.000166	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.16e-05	0.000165	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	1.16e-05	0.000164	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	1.15e-05	0.000163	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	1.15e-05	0.000163	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	1.15e-05	0.000163	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	1.14e-05	0.000161	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	1.11e-05	0.000157	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	1.11e-05	0.000157	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.1e-05	0.000156	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	1.1e-05	0.000156	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	1.1e-05	0.000156	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	1.1e-05	0.000156	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	1.08e-05	0.000153	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	1.07e-05	0.000152	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.06e-05	0.000151	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	1.06e-05	0.000151	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.06e-05	0.00015	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GNB3—type 2 diabetes mellitus	1.04e-05	0.000147	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.04e-05	0.000147	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HMOX1—type 2 diabetes mellitus	1.03e-05	0.000146	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	1.03e-05	0.000146	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.03e-05	0.000146	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	1.03e-05	0.000146	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	1.02e-05	0.000144	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.01e-05	0.000143	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	9.97e-06	0.000141	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	9.95e-06	0.000141	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	9.95e-06	0.000141	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	9.91e-06	0.00014	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	9.88e-06	0.00014	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	9.71e-06	0.000138	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	9.67e-06	0.000137	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	9.61e-06	0.000136	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	9.6e-06	0.000136	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	9.54e-06	0.000135	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	9.54e-06	0.000135	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	9.52e-06	0.000135	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	9.43e-06	0.000134	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOB—type 2 diabetes mellitus	9.37e-06	0.000133	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	9.28e-06	0.000132	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	9.24e-06	0.000131	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	9.2e-06	0.00013	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	9.05e-06	0.000128	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	9.04e-06	0.000128	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	8.96e-06	0.000127	CbGpPWpGaD
Nabumetone—PTGS2—Disease—LPL—type 2 diabetes mellitus	8.94e-06	0.000127	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	8.85e-06	0.000125	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	8.75e-06	0.000124	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	8.74e-06	0.000124	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	8.74e-06	0.000124	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	8.74e-06	0.000124	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	8.74e-06	0.000124	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	8.49e-06	0.00012	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.41e-06	0.000119	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	8.39e-06	0.000119	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	8.38e-06	0.000119	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	8.33e-06	0.000118	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CCR5—type 2 diabetes mellitus	8.24e-06	0.000117	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	8.23e-06	0.000117	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.23e-06	0.000117	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	8.19e-06	0.000116	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.14e-06	0.000115	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	8.08e-06	0.000114	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	8.07e-06	0.000114	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	8.05e-06	0.000114	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.98e-06	0.000113	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	7.94e-06	0.000112	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	7.91e-06	0.000112	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.89e-06	0.000112	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	7.84e-06	0.000111	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	7.82e-06	0.000111	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	7.79e-06	0.00011	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	7.68e-06	0.000109	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IRS2—type 2 diabetes mellitus	7.66e-06	0.000109	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	7.63e-06	0.000108	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CALM1—type 2 diabetes mellitus	7.52e-06	0.000107	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOE—type 2 diabetes mellitus	7.5e-06	0.000106	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	7.49e-06	0.000106	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOA1—type 2 diabetes mellitus	7.41e-06	0.000105	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	7.33e-06	0.000104	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	7.31e-06	0.000104	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	7.27e-06	0.000103	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	7.13e-06	0.000101	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	7.13e-06	0.000101	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	7.12e-06	0.000101	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	7.03e-06	9.96e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	6.99e-06	9.9e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS2—type 2 diabetes mellitus	6.98e-06	9.9e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.95e-06	9.85e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	6.94e-06	9.84e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	6.94e-06	9.84e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	6.94e-06	9.84e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	6.9e-06	9.78e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	6.89e-06	9.76e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	6.78e-06	9.61e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—INS—type 2 diabetes mellitus	6.76e-06	9.57e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	6.74e-06	9.56e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	6.7e-06	9.49e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IRS1—type 2 diabetes mellitus	6.69e-06	9.48e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	6.62e-06	9.37e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	6.41e-06	9.08e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—INS—type 2 diabetes mellitus	6.4e-06	9.07e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	6.3e-06	8.93e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	6.28e-06	8.9e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.25e-06	8.85e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	6.23e-06	8.83e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	6.23e-06	8.83e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	6.23e-06	8.83e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	6.21e-06	8.79e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	6.19e-06	8.78e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKT2—type 2 diabetes mellitus	6.19e-06	8.77e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	6.11e-06	8.66e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	6.06e-06	8.59e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.98e-06	8.47e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	5.93e-06	8.4e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.92e-06	8.4e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	5.92e-06	8.4e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	5.88e-06	8.34e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	5.7e-06	8.07e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	5.63e-06	7.98e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS3—type 2 diabetes mellitus	5.62e-06	7.96e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	5.62e-06	7.96e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	5.49e-06	7.78e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	5.47e-06	7.75e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.47e-06	7.75e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	5.42e-06	7.68e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	5.4e-06	7.65e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	5.4e-06	7.65e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—INS—type 2 diabetes mellitus	5.36e-06	7.6e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	4.92e-06	6.97e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.7e-06	6.66e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	4.7e-06	6.66e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	4.65e-06	6.6e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.65e-06	6.6e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	4.63e-06	6.57e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	4.57e-06	6.48e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	4.44e-06	6.29e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	4.32e-06	6.12e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	4.24e-06	6.01e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SRC—type 2 diabetes mellitus	4.15e-06	5.89e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.15e-06	5.88e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	4.13e-06	5.86e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	4.03e-06	5.71e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.98e-06	5.63e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.82e-06	5.41e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.74e-06	5.3e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	3.71e-06	5.26e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EGFR—type 2 diabetes mellitus	3.64e-06	5.16e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3.63e-06	5.14e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	3.56e-06	5.05e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	3.55e-06	5.03e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	3.51e-06	4.98e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.09e-06	4.38e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.03e-06	4.3e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—type 2 diabetes mellitus	2.8e-06	3.97e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.78e-06	3.94e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	2.72e-06	3.86e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.66e-06	3.77e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.66e-06	3.77e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKT1—type 2 diabetes mellitus	2.58e-06	3.66e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.43e-06	3.45e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	2.16e-06	3.06e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.22e-06	1.73e-05	CbGpPWpGaD
